The World Health Organization (WHO)'s Global TB Program has released Frequently asked questions about the implementation of the new WHO recommendation on the use of the shorter MDR-TB regimen under programmatic conditions.
These Frequently asked questions are to be read alongside the WHO treatment guidelines for drug-resistant tuberculosis, 2016 update released by the World Health Organization's Global TB Program in May 2016.
The Frequently asked questions can be accessed here.